Home > Healthcare > Biotechnology > Biopharma > Gene Vector Market

Gene Vector Market Size

Report ID: GMI5693
Published Date: May 2023
Report Format: PDF

Download Free Sample

Gene Vector Market Size

Gene Vector Market size was valued at more than USD 1.20 billion in 2022 and will progress tremendously to reach over USD 4.11 billion by 2032 at 13.1% CAGR. Increase in prevalence of genetic disorders, development of more advanced gene editing technologies, and increasing demand for personalized medicine will drive the market growth.

To get key market trends

Download Free Sample

In October 2021, as per the report published by the Genetic and Rare Diseases (GARD) Information Center, more than 30 million people in the United States are thought to be affected by one of the more than 7,000 rare diseases that exist. Cells and genetically modified cells are "living drugs" that repair and replace damaged tissues or ill organs, which makes them fundamentally different from medications and surgery. Due to these characteristics, they are used to treat a variety of conditions.

Gene Vector Market Report Attributes
Report Attribute	Details
Base Year:	2022
Gene Vector Market Size in 2022:	USD 1.20 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	13.1%
2032 Value Projection:	USD 4.11 Billion
Historical Data for:	2018 to 2022
No. of Pages:	153
Tables, Charts & Figures:	272
Segments covered:	Vector Type, Application, Diseases, End-User, and Region
Growth Drivers:	Rising prevalence of genetic disorders, cancer, and infectious diseases Development of more advanced gene editing technologies Increasing demand for personalized medicine Increase in R&D investments for the development of gene therapy Ongoing research into viral vector-based gene therapies
Pitfalls & Challenges:	Challenges associated with the regulatory approval of gene vectors development High cost of gene therapies

Learn more about the key segments shaping this market

Download Free Sample

A gene vector, as related to molecular biology, is a DNA molecule (often plasmid or virus) that is used as a vehicle to carry a particular DNA segment into a host cell as part of a cloning or recombinant DNA technique. Gene vectors can be applied in gene therapy to treat different diseases such as cancer, metabolic diseases, heart defects, infectious diseases, and neurodegenerative disorders.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for gene vector crossed USD 1.20 billion in 2022 and will grow at 13.1% CAGR between 2023 and 2032.

Gene vector demand across gene therapy will grow substantially through 2032 due to its increasing use in the treatment of cancer, chronic disease, infectious disease, and blood disorders.

North America gene vector market held 53.8% revenue share in 2022 owing to the presence of a large number of R&D centers and institutes developing advanced gene therapies.

Cobra Biologics, SIRION Biotech, Lonza, Oxford Biomedica, Novasep, Spark Therapeutics, Kaneka Eurogentec, and Brammer Bio are some of the major companies in the market.